Supplementary Figure S4 from Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells

2026 Open access

Read full text

Authors: Xuxu Gou, Huadong Chen, Morgan E. Diolaiti, Alan Ashworth

DOI: 10.1158/2767-9764.30987080

Cited by: 0

Abstract

Supplementary Figure S4, related to Figure 3. TP53 mutation enriched in synergistic cell lines.

PARP inhibition in cancer therapy Cancer-related Molecular Pathways Cancer Stress Anesthesia and Immune Response